BWAM
GSK icon

Boyd Watterson Asset Management’s GSK GSK Stock Holding History

Boyd Watterson Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Hold
419
– – 0.01% 238
2026
Q1 		$23.1K Hold
419
– – 0.01% 241
2025
Q4 		$20.5K Hold
419
– – 0.01% 246
2025
Q3 		$18.1K Sell
419
-48
-10% -$1.88K 0.01% 249
2025
Q2 		$17.9K Buy
467
+222
+91% +$8.48K 0.01% 257
2025
Q1 		$9.49K Hold
245
– – ﹤0.01% 299
2024
Q4 		$8.29K Hold
245
– – ﹤0.01% 315
2024
Q3 		$10K Sell
245
-6
-2% -$245 ﹤0.01% 309
2024
Q2 		$9.66K Hold
251
– – ﹤0.01% 311
2024
Q1 		$10.8K Hold
251
– – ﹤0.01% 304
2023
Q4 		$9.3K Hold
251
– – ﹤0.01% 309
2023
Q3 		$9.1K Hold
251
– – ﹤0.01% 305
2023
Q2 		$8.95K Hold
251
– – ﹤0.01% 310
2023
Q1 		$8.93K Hold
251
– – ﹤0.01% 313
2022
Q4 		$8.82K Buy
+251
New +$8.36K ﹤0.01% 316
2016
Q4 		– Sell
-6,452
Closed -$348K – 149
2016
Q3 		$348K Sell
6,452
-1,778
-22% -$97.5K 0.17% 123
2016
Q2 		$446K Sell
8,230
-63
-0.8% -$3.32K 0.21% 120
2016
Q1 		$420K Buy
8,293
+1,731
+26% +$86.2K 0.2% 121
2015
Q4 		$331K Sell
6,562
-2,848
-30% -$145K 0.16% 124
2015
Q3 		$452K Buy
9,410
+942
+11% +$49K 0.19% 119
2015
Q2 		$441K Buy
8,468
+32
+0.4% +$1.8K 0.17% 131
2015
Q1 		$487K Buy
8,436
+2,079
+33% +$119K 0.2% 122
2014
Q4 		$340K Sell
6,357
-924
-13% -$51.7K 0.15% 134
2014
Q3 		$418K Buy
7,281
+271
+4% +$16.6K 0.18% 134
2014
Q2 		$469K Sell
7,010
-24
-0.3% -$1.62K 0.2% 126
2014
Q1 		$470K Buy
7,034
+725
+11% +$49K 0.22% 121
2013
Q4 		$421K Sell
6,309
-1,794
-22% -$116K 0.2% 128
2013
Q3 		$508K Buy
8,103
+680
+9% +$43.8K 0.24% 99
2013
Q2 		$464K Buy
+7,423
New +$471K 0.24% 99

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Boyd Watterson Asset Management's GSK Position: Q2 2026 in Review

Boyd Watterson Asset Management held its GSK (GSK) position steady in Q2 2026 at 419 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #238.

Boyd Watterson Asset Management first reported a position in GSK in Q2 2013 and has held it in 29 quarters since. The position peaked at $508K in Q3 2013. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Boyd Watterson Asset Management held 419 shares of GSK worth $22K as of Q2 2026.
  • Boyd Watterson Asset Management left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Boyd Watterson Asset Management's portfolio in Q2 2026, its #238 holding.
  • Boyd Watterson Asset Management first reported a position in GSK in Q2 2013 and has held it in 29 quarters since.
  • Boyd Watterson Asset Management's GSK position peaked at $508K in Q3 2013.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Boyd Watterson Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.